Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of immunobiologic markers in primary and recurrent glioblastoma.

Journal of neuro-oncology - 1 Apr 2018

Rahman Maryam, Kresak Jesse, Yang Changlin, Huang Jianping, Hiser Wesley, Kubilis Paul, Mitchell Duane

Abstract excerpt

Glioblastoma (GBM) generates a varied immune response and understanding the immune microenvironment may lead to novel immunotherapy treatments modalities. The goal of this study was to evaluate the expression of immunologic markers of potential clinical significance in primary versus recurrent GBM and assess the relationship between these markers and molecular characteristics of GBM. Human GBM samples were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD8 Antigens
Share to DNA Modification Methylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Repair Enzymes

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Lymphocytes, Tumor-Infiltrating

Share to Neoplasm Grading

Share to X-linked Nuclear Protein

Source

Open in PubMed Open full text

Identifiers

PMID: 29302887
DOI: 10.1007/s11060-017-2732-1
PMCID: PMC5849511

Genes

CTLA4
IDH1
MGMT
ATRX

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of immunobiologic markers in primary and recurrent glioblastoma.PMID 29302887Read ↗

RRN3P2, RPL7AP64, ACTR3C, & RPL7AP30 as Novel Prognostic Biomarkers for Glioblastoma (GBM): A Bioinformatics-Based AnalysisSemantic proximity Read ↗

RRN3P2, RPL7AP64, ACTR3C, & RPL7AP30 as Novel Prognostic Biomarkers for Glioblastoma (GBM): A Bioinformatics-Based AnalysisSemantic proximity Read ↗

Immunophenotypic Profile of Adult Glioblastoma IDH-Wildtype Microenvironment: A Cohort StudySemantic proximity Read ↗

Immunogenetics of glioblastoma: the future of personalized patient managementSemantic proximity Read ↗

Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.Semantic proximity Read ↗

Predictive Analyses of Prognostic-Related Immune Genes and Immune Infiltrates for GlioblastomaSemantic proximity Read ↗

Molecular Heterogeneity and Immunosuppressive Microenvironment in GlioblastomaSemantic proximity Read ↗

Genomic Landscape and Immunological Profile of Glioblastoma in East Asian PatientsSemantic proximity Read ↗

Tumor-infiltrating CD8+ sub-populations in primary and recurrent glioblastoma: An in-silico studySemantic proximity Read ↗

Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent GlioblastomasSemantic proximity Read ↗

Exploring the immune environment of glioblastoma through single-cell RNA sequencing in humanized mouse modelsSemantic proximity Read ↗

Identification of m6A methyltransferase-related WTAP and ZC3H13 predicts immune infiltrates in glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.